Cytodyn Inc (CYDY)

[Chuckles759]

I know that CytoDyn is specifically targeting COVID-19 diagnosis and Leronlimab as a treatment for different severity levels.

For those familiar with the clinical trial inclusion/exclusion criteria does the patient just have to "exhibit COVID-19 like symptoms" or do they have to have a positive diagnosis?

The reason I ask is that there may some new "COVID-19 like" illnesses that the patient does not test COVID-19 positive.

https://news.yahoo.com/coronavirus-kazakhstan-denies-unknown-pneumonia-170329227.html

Didn't know if/when leronlimab is approved for COVID-19 that a patient has to test positive before leronlimab can be prescribed.

I know that medical professionals have to very precisely "code" diagnosis in their systems for not only insurance but for CDC/FDA reporting. Much of this "code" drives what the doctors can do for the patient.